Journal article
Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.
Abstract
BACKGROUND: The optimal aspirin dose for the prevention of cardiovascular events remains controversial.
OBJECTIVE: To assess the incidence of and risk factors for adverse clinical outcomes by investigator-determined aspirin dose in a primary prevention trial.
Authors
Steinhubl SR; Bhatt DL; Brennan DM; Montalescot G; Hankey GJ; Eikelboom JW; Berger PB; Topol EJ
Journal
Annals of Internal Medicine, Vol. 150, No. 6, pp. 379–386
Publisher
American College of Physicians
Publication Date
March 17, 2009
DOI
10.7326/0003-4819-150-6-200903170-00006
ISSN
1056-8751